These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists. Baraldi PG; Cacciari B; Pineda de Las Infantas MJ; Romagnoli R; Spalluto G; Volpini R; Costanzi S; Vittori S; Cristalli G; Melman N; Park KS; Ji XD; Jacobson KA J Med Chem; 1998 Aug; 41(17):3174-85. PubMed ID: 9703463 [TBL] [Abstract][Full Text] [Related]
3. Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: insight into the receptor activation switch. Dal Ben D; Buccioni M; Lambertucci C; Kachler S; Falgner N; Marucci G; Thomas A; Cristalli G; Volpini R; Klotz KN Biochem Pharmacol; 2014 Jan; 87(2):321-31. PubMed ID: 24161786 [TBL] [Abstract][Full Text] [Related]
4. The role of intraspinal adenosine A1 receptors in sympathetic regulation. Peng SC; Ho CM; Ho ST; Tsai SK; Su CK Eur J Pharmacol; 2004 May; 492(1):49-55. PubMed ID: 15145705 [TBL] [Abstract][Full Text] [Related]
5. 2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies. Franchetti P; Cappellacci L; Marchetti S; Trincavelli L; Martini C; Mazzoni MR; Lucacchini A; Grifantini M J Med Chem; 1998 May; 41(10):1708-15. PubMed ID: 9572897 [TBL] [Abstract][Full Text] [Related]
6. New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine. Beukers MW; Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Brussee J; IJzerman AP J Med Chem; 2004 Jul; 47(15):3707-9. PubMed ID: 15239649 [TBL] [Abstract][Full Text] [Related]
7. Negative chronotropic response to adenosine receptor stimulation in rat right atria after run training. Priviero F; De Nucci G; Antunes E; Zanesco A Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):741-3. PubMed ID: 15554918 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and adenosine receptor affinity and potency of 8-alkynyl derivatives of adenosine. Lambertucci C; Costanzi S; Vittori S; Volpini R; Cristalli G Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1153-7. PubMed ID: 11562976 [TBL] [Abstract][Full Text] [Related]
10. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor. Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A3 receptor. Volpini R; Buccioni M; Dal Ben D; Lambertucci C; Lammi C; Marucci G; Ramadori AT; Klotz KN; Cristalli G J Med Chem; 2009 Dec; 52(23):7897-900. PubMed ID: 19839592 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of new N6-substituted adenosine-5'-N-methylcarboxamides as A3 adenosine receptor agonists. Devine SM; Gregg A; Figler H; McIntosh K; Urmaliya V; Linden J; Pouton CW; White PJ; Bottle SE; Scammells PJ Bioorg Med Chem; 2010 May; 18(9):3078-87. PubMed ID: 20385496 [TBL] [Abstract][Full Text] [Related]
13. [Advances in the study of A2B adenosine receptor antagonists]. Wei J; Yu WQ; Gao QZ Yao Xue Xue Bao; 2008 Mar; 43(3):241-6. PubMed ID: 18630258 [TBL] [Abstract][Full Text] [Related]
14. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes. Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243 [TBL] [Abstract][Full Text] [Related]
15. Humoral effects of selective adenosine agonists in spontaneously hypertensive rats. Sala C; Monopoli A; Alberti C; Casati C; Ongini E; Zanchetti A; Morganti A J Hypertens; 1996 Jan; 14(1):75-9. PubMed ID: 12013498 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of carbocyclic analogues of MECA and NECA 1,2-disubstituted as potential adenosine receptor agonists. Besada P; González-Moa MJ; Terán C; Teijeira M; Santana L Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):759-61. PubMed ID: 14565272 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists. Baraldi PG; Fruttarolo F; Tabrizi MA; Romagnoli R; Preti D; Bovero A; Pineda de Las Infantas MJ; Moorman A; Varani K; Borea PA J Med Chem; 2004 Oct; 47(22):5535-40. PubMed ID: 15481989 [TBL] [Abstract][Full Text] [Related]
18. A series of 2,4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A3 receptor. Heitman LH; Göblyös A; Zweemer AM; Bakker R; Mulder-Krieger T; van Veldhoven JP; de Vries H; Brussee J; Ijzerman AP J Med Chem; 2009 Feb; 52(4):926-31. PubMed ID: 19161279 [TBL] [Abstract][Full Text] [Related]
19. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake. Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526 [TBL] [Abstract][Full Text] [Related]
20. A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists. de Zwart M; Link R; von Frijtag Drabbe Künzel JK; Cristalli G; Jacobson KA; Townsend-Nicholson A; IJzerman AP Nucleosides Nucleotides; 1998 Jun; 17(6):969-85. PubMed ID: 9708319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]